Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 466–480 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1328 MPZ Full Length Gene Sequence Analysis (Charcot‑Marie‑Tooth Disease) Test This test analyzes the entire MPZ gene to detect pathogenic variants associated with Charcot‑Marie‑Tooth disease type 1B.	Peripheral Blood	3-4 weeks	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MPZ gene", "Single-nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["No fasting or special preparation is required for peripheral blood."] Indications ["Suspected Charcot‑Marie‑Tooth disease type 1B", "Confirmation of CMT1B diagnosis", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 81319-6 ICD-10: G60.0 Clinical summary This test analyzes the entire MPZ gene to detect pathogenic variants associated with Charcot‑Marie‑Tooth disease type 1B.
TEST-3822 MRE11 Gene Ataxia-Telangiectasia-Like Disorder Genetic Test This genetic test identifies pathogenic variants in the MRE11 gene, confirming a diagnosis of Ataxia-Telangiectasia-Like Disorder (ATLD).	Peripheral whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MRE11 gene"] Parameters [] Preparation ["No special preparation required"] Indications ["Individuals presenting with progressive cerebellar ataxia", "Oculomotor apraxia", "Family history suggestive of autosomal recessive inheritance", "Cancer risk stratification"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G11.3 Clinical summary This genetic test identifies pathogenic variants in the MRE11 gene, confirming a diagnosis of Ataxia-Telangiectasia-Like Disorder (ATLD).
TEST-6173 MRPL3 Gene Genetic Test for Combined Oxidative Phosphorylation Deficiency Type 9 This test identifies pathogenic variants in the MRPL3 gene associated with Combined Oxidative Phosphorylation Deficiency Type 9.	Peripheral whole blood (3–5 mL in EDTA tube), extracted genomic DNA, or dried blood spot on FTA card	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MRPL3 gene coding region", "MRPL3 gene flanking intronic boundaries", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No fasting required", "No medication adjustments typically required"] Indications ["Suspected Combined Oxidative Phosphorylation Deficiency Type 9", "Family cascade screening for MRPL3 variants", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 94047-2 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the MRPL3 gene associated with Combined Oxidative Phosphorylation Deficiency Type 9.
TEST-4165 MT-CO2 Gene (Cytochrome c Oxidase 2 Deficiency) Genetic Test This test identifies pathogenic variants in the MT-CO2 gene, which are associated with cytochrome c oxidase deficiency and related neurological disorders.	Blood, Extracted DNA, FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MT-CO2 gene", "Mitochondrial DNA variants"] Parameters [] Preparation ["No special preparation required for blood draw", "Inform phlebotomist of bleeding disorders or anticoagulant use"] Indications ["Suspected cytochrome c oxidase deficiency", "Diagnosis of Leigh syndrome", "Investigation of mitochondrial dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 91716-1 ICD-10: E88.49 Clinical summary This test identifies pathogenic variants in the MT-CO2 gene, which are associated with cytochrome c oxidase deficiency and related neurological disorders.
TEST-4177 MT-TE Gene Mitochondrial Myopathy (Infantile, Transient) Test This test evaluates the MT-TE gene for pathogenic variants associated with infantile transient mitochondrial myopathy.	Whole blood (peripheral venipuncture) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MT-TE gene"] Parameters [] Preparation ["Mandatory genetic counselling prior to specimen collection"] Indications ["Infants presenting with unexplained hypotonia or cardiac instability", "Neonates with suspected mitochondrial myopathy"] Measurement technique Confirm with laboratory Codes LOINC: 81261-8 ICD-10: G71.3 Clinical summary This test evaluates the MT-TE gene for pathogenic variants associated with infantile transient mitochondrial myopathy.
TEST-4802 MT-TK Gene Analysis (MERRF Syndrome) Test This test analyzes the entire MT-TK mitochondrial gene to detect pathogenic variants associated with MERRF syndrome.	Whole blood (EDTA), extracted DNA, or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MT-TK gene", "Copy number analysis of the MT-TK gene"] Parameters [] Preparation ["Inform physician and lab about all current medications and supplements", "A 30-minute genetic counselling session is required", "No fasting is necessary"] Indications ["Suspected MERRF syndrome based on clinical presentation", "Family history of mitochondrial disorders", "Need for genetic counseling and family risk assessment", "Pregnancy planning in affected families"] Measurement technique Confirm with laboratory Codes LOINC: 58274-6 ICD-10: E88.49 Clinical summary This test analyzes the entire MT-TK mitochondrial gene to detect pathogenic variants associated with MERRF syndrome.
TEST-5112 MT‑CYB Gene Mitochondrial Encephalomyopathy Genetic Test This test evaluates the MT‑CYB gene for pathogenic variants associated with mitochondrial encephalomyopathy (Complex III deficiency).	Whole Blood (EDTA) or Extracted Genomic DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MT‑CYB gene sequence", "Pathogenic variants (SNVs, indels, CNAs)"] Parameters [] Preparation ["No specific fasting required", "Avoid abrupt withdrawal of medications like antiepileptics or metabolic supplements"] Indications ["Suspected Complex III deficiency", "Unexplained neurological symptoms", "Family history of mitochondrial disease"] Measurement technique Confirm with laboratory Codes LOINC: 101357-6 ICD-10: E88.40 Clinical summary This test evaluates the MT‑CYB gene for pathogenic variants associated with mitochondrial encephalomyopathy (Complex III deficiency).
TEST-3857 MT‑TV Gene Sequencing (NGS) for Ataxia, Progressive Seizures, Mental Deterioration & Hearing Loss Test This diagnostic test evaluates the MT‑TV gene for mutations associated with progressive neurological symptoms.	Peripheral whole blood	14–21 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MT‑TV gene mutations", "Copy number variations (CNV) in MT‑TV gene"] Parameters [] Preparation [] Indications ["Progressive neurological symptoms", "Suspected mitochondrial disorder", "Family history of related conditions"] Measurement technique Confirm with laboratory Codes LOINC: 94306-8 ICD-10: G31.9 Clinical summary This diagnostic test evaluates the MT‑TV gene for mutations associated with progressive neurological symptoms.
TEST-5350 MTAP Gene Myopathy, Limb Girdle with Bone Fragility Genetic Test This test identifies pathogenic variants in the MTAP gene associated with limb-girdle muscular dystrophy and bone fragility.	Whole Blood, Extracted DNA, One Drop Blood on FTA Card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MTAP gene", "Copy Number Variations (CNVs) in the MTAP gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any anticoagulant therapy"] Indications ["Suspected MTAP-related limb-girdle muscular dystrophy", "Family history of MTAP-related disorders", "Diagnostic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 81263-9 ICD-10: G71.0, M89.8 Clinical summary This test identifies pathogenic variants in the MTAP gene associated with limb-girdle muscular dystrophy and bone fragility.
TEST-4039 MTRR Gene (Homocystinuria-Megaloblastic Anemia, cblE Type) Genetic Test This test evaluates the MTRR gene for pathogenic variants associated with cblE-type homocystinuria-megaloblastic anemia.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MTRR gene pathogenic variants", "Single-nucleotide variants", "Insertions", "Deletions", "Duplications"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Clinical suspicion of cblE-type homocystinuria", "Family history of homocystinuria", "Confirmation of biochemical findings"] Measurement technique Confirm with laboratory Codes LOINC: 81318-0 ICD-10: E72.19 Clinical summary This test evaluates the MTRR gene for pathogenic variants associated with cblE-type homocystinuria-megaloblastic anemia.
TEST-4597 MYD88 Gene Recurrent Pyogenic Bacterial Infections Due to MYD88 Deficiency Genetic Test This genetic test identifies pathogenic variants in the MYD88 gene associated with primary immunodeficiency.	Peripheral whole blood (3–5 mL in EDTA tube), extracted genomic DNA, or dried blood spot on FTA card.	3–4 Weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYD88 gene", "Coding regions and splice junctions of the MYD88 gene"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["No fasting required.", "Clinical history review and genetic counselling session recommended."] Indications ["Suspected MYD88 deficiency", "Recurrent pyogenic bacterial infections", "Family history of primary immunodeficiency"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: D84.9, D84.8 Clinical summary This genetic test identifies pathogenic variants in the MYD88 gene associated with primary immunodeficiency.
TEST-5377 MYH3 Gene Distal Arthrogryposis Type 2B (DA2B) Genetic Test This genetic test evaluates the MYH3 gene for pathogenic variants associated with Distal Arthrogryposis Type 2B (DA2B).	Peripheral Whole Blood, Extracted DNA, or FTA Card Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYH3 gene", "Copy Number Variations (CNV) in the MYH3 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected Distal Arthrogryposis Type 2B (DA2B)", "Family history of MYH3-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 77998-9 ICD-10: Q74.3 Clinical summary This genetic test evaluates the MYH3 gene for pathogenic variants associated with Distal Arthrogryposis Type 2B (DA2B).
TEST-4141 MYH6 Gene (Sick Sinus Syndrome Type 3) Genetic Test This test detects pathogenic variants in the MYH6 gene associated with sick sinus syndrome type 3.	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in MYH6 gene", "Coding exons", "Splice sites", "Flanking intronic regions"] Parameters [] Preparation ["Avoid taking any dietary supplements containing biotin for 48 hours before collection"] Indications ["Patients with unexplained bradycardia", "Patients with sinus node dysfunction", "Family history of early-onset sinus node disease", "Asymptomatic family members after confirmed familial mutation"] Measurement technique Confirm with laboratory Codes LOINC: 102384-2 ICD-10: I49.5 Clinical summary This test detects pathogenic variants in the MYH6 gene associated with sick sinus syndrome type 3.
TEST-4057 MYLK Gene Familial Thoracic Aortic Aneurysm Type 7 Genetic Test This test analyzes the MYLK gene for mutations linked to familial thoracic aortic aneurysm type 7, a hereditary condition increasing the risk of aortic dissection.	Whole Blood (EDTA Tube) or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYLK gene"] Parameters [] Preparation [] Indications ["Individuals with a family history of thoracic aortic aneurysm or sudden cardiac death", "Prophylactic surveillance for at-risk individuals", "Cascade screening of family members"] Measurement technique Confirm with laboratory Codes LOINC: 82847-8 ICD-10: I71.2 Clinical summary This test analyzes the MYLK gene for mutations linked to familial thoracic aortic aneurysm type 7, a hereditary condition increasing the risk of aortic dissection.
TEST-2644 Myotonic Dystrophy Type 1 (DM1) Genetic Test This test detects and quantifies CTG trinucleotide repeat expansions in the DMPK gene, confirming the diagnosis of Myotonic Dystrophy Type 1.	Peripheral whole blood	4-5 business days (sample by Monday 11 AM for Friday results)	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CTG trinucleotide repeat expansion", "DMPK gene sequence"] Parameters [{"name": "CTG Repeat Count", "reference_range": "< 50 repeats (Normal)"}] Preparation ["No fasting required", "No dietary restrictions"] Indications ["Suspected Myotonic Dystrophy Type 1", "Family history of DM1", "Differential diagnosis of neuromuscular disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94123-0 ICD-10: G71.11 Clinical summary This test detects and quantifies CTG trinucleotide repeat expansions in the DMPK gene, confirming the diagnosis of Myotonic Dystrophy Type 1.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.